SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-176573
Filing Date
2022-06-17
Accepted
2022-06-17 16:42:00
Documents
15
Period of Report
2022-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d332106d8k.htm   iXBRL 8-K 32371
2 EX-10.1 d332106dex101.htm EX-10.1 26827
7 GRAPHIC g332106dsp001.jpg GRAPHIC 7086
  Complete submission text file 0001193125-22-176573.txt   246022

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cmraw-20220613.xsd EX-101.SCH 3947
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmraw-20220613_def.xml EX-101.DEF 14551
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmraw-20220613_lab.xml EX-101.LAB 24109
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmraw-20220613_pre.xml EX-101.PRE 15644
9 EXTRACTED XBRL INSTANCE DOCUMENT d332106d8k_htm.xml XML 5402
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 221024534
SIC: 2834 Pharmaceutical Preparations